8/15/17

CDC Makes Significant Investment to Combat Antibiotic Resistance


By on 7:17 AM

The Centers for Disease Control and Prevention (CDC) recently announced it was providing $77 million to help state and local health departments fight antibiotic resistance.

CDC is investing in every state to combat antibiotic-resistant foodborne infections and infections in healthcare facilities and communities.

"More than 23,000 people in the United States die each year from infections caused by antibiotic resistance," said CDC Director Brenda Fitzgerald, MD, in a press release. "CDC is committed to helping states and cities strengthen their ability to combat antibiotic resistance, and these funds will help state efforts to keep people safe."

As part of the investment, CDC is making enhancements to its Antibiotic Resistance Laboratory Network (AR Lab Network). The investment is aimed at improving the detection of known and emerging antibiotic resistance threats. CDC states that data generated by the AR Lab Network can help improve infection control in healthcare facilities and enable more rapid and effective responses to outbreaks.

The 2017 funding enhances current AR Lab Network activities by doing the following:
  • Increasing nationwide testing for Candida. This includes the emerging drug-resistant Candida auris fungi. C. auris can cause invasive and often deadly infections that are resistant to multiple antifungal drugs.
  • Strengthening national tuberculosis surveillance and infrastructure. This will be made possible by the addition of a new national laboratory equipped to perform DNA sequencing of Mycobacterium tuberculosis gathered from newly diagnosed patients in the United States.
  • Enhancing detection of drug-resistant gonorrhea threats using whole genome sequencing. Enhanced gonorrhea surveillance will identify when and how drug-resistant strains emerge and spread. This information could lead to more rapid outbreak response, and help stop antibiotic-resistant gonorrhea from spreading further. It will also help clinicians make more accurate treatment decisions for patients.
CDC made the public health program investments through its Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement.

For assistance with development of an antimicrobial stewardship program, contact Infection Control Consulting services (ICCS) by clicking here. ICCS is a leading, national consulting firm that provides expert infection prevention and control services to healthcare facilities and organizations.

 

0 comments:

Post a Comment